Tanshinone IIA Inhibits Osteosarcoma Growth through a Src Kinase-Dependent Mechanism.
Chao HuXiaobin ZhuTaogen ZhangZhouming DengYuanlong XieFeifei YanLin Cai
Published in: Evidence-based complementary and alternative medicine : eCAM (2021)
Tanshinone IIA plays an antiosteosarcoma role in vitro and in vivo and inhibits the progression of osteosarcoma mediated by Src downstream of the MAPK/ERK and PI3K/AKt signaling pathways.